insights_auto
Outlook: 38.6% bullish·6.8% bearish
Go to analysischevron_right
PFE:NYSE
Pfizer Inc
$28.72
arrow_downward
-0.03%(-0.010) 1D
$28.72
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 29, 4:03:11 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFE...
Open
$28.60
High
$28.76
Low
$28.26
Mkt. cap
163.69B
Avg. vol.
33.64M
Volume
33.30M
Dividend
5.99%
Quarterly dividend
$0.43
Ex-dividend date
Jul 24, 2026
P/E ratio
38.03
52-wk high
$29.21
52-wk low
$23.62
EPS
$0.76
Beta
0.34
Shares outstanding
5.70B
No. of employees
75K
Open
$28.60
High
$28.76
Low
$28.26
Mkt. cap
163.69B
Avg. vol.
33.64M
Volume
33.30M
Dividend
5.99%
Quarterly dividend
$0.43
Ex-dividend date
Jul 24, 2026
P/E ratio
38.03
52-wk high
$29.21
52-wk low
$23.62
EPS
$0.76
Beta
0.34
Shares outstanding
5.70B
No. of employees
75K
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
With the Market Flashing Warning Signs Not Seen Since the Dot-Com Bust, Is Pfizer's 6% Yield a Safe Haven or a Trap?
kalkine.ca
·
2 hours ago
Pfizer (NYSE:PFE) Stock: Newer Medicines Carry the Outlook as COVID Sales Fall Faster
AD HOC NEWS
·
2 hours ago
Pfizer stock after-hours at EUR 25.25: minus 0.16 percent versus prior close
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer Inc
CEOAlbert Bourla
Employees75K
Founded1849
HeadquartersNew York, New York, United States
SectorPharmaceutical industry
Websitepfizer.com